Baricitinib

SI-1064

Baricitinib, >98%

CAS No. : [1187594-09-7]

MDL No. : MFCD21608464

Synonyms : INCB028050; LY3009104

IUPAC Name : 2-(3-(4-(7H-Pyrrolo[2,3-d]pyrimidin-4-yl)-1H-pyrazol-1-yl)-1-(ethylsulfonyl)azetidin-3-yl)acetonitrile

Price And Availability
Pack Size	Price in USD	Add To Shopping Cart	Availability	Shipping Status
5MG	75.00		In Stock	Estimated to ship on 20 September 2026
10MG	125.00		In Stock	Estimated to ship on 20 September 2026
25MG	255.00		In Stock	Estimated to ship on 20 September 2026
50MG	455.00		In Stock	Estimated to ship on 20 September 2026
100MG	855.00		In Stock	Estimated to ship on 20 September 2026
250MG	1655.00		In Stock	Estimated to ship on 20 September 2026
500MG	2655.00		In Stock	Estimated to ship on 20 September 2026

Applications : Baricitinib is a selective and orally bioavailable JAK1 and JAK2 inhibitor, used for the treatment of rheumatoid arthritis in adults. Also this is a COVID-19 related research chemical.

References : Fridman J. S. et al.: J. Immunol., 184(9), 5298-5307, 2010; Jabbari A. et al. EBioMedicine 2(4), 351-5, 2015; Khan I. M. et al.: Int. J. Obes (Lond) 39(11), 1607-1618, 2015.

Storage : Keep container tightly closed under nitrogen or argon and refrigerate for long-term shelf life.

Caution : In case of contact with skin or eyes, rinse immediately with plenty of water and seek medical advice. Wear suitable protective clothing and gloves.